Daejeon, South Korea

Jaephil Do

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tomocube, Inc.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jaephil Do in Mycoplasma Detection

Introduction

Jaephil Do is an accomplished inventor based in Daejeon, South Korea. He has made significant contributions to the field of biomedical engineering, particularly in the detection of mycoplasma. His innovative approach combines advanced imaging techniques with quantitative analysis to enhance detection methods.

Latest Patents

Jaephil Do holds a patent for a "Method and apparatus for detecting mycoplasma using 3-D quantitative phase image measurement." This patent describes a method that generates a three-dimensional quantitative phase image of a sample. The process involves characterizing the sample by quantifying a phase shift derived from light passing through it. By analyzing the behavioral characteristics of the generated 3-D quantitative phase image, the method determines whether the sample is infected.

Career Highlights

Jaephil Do is currently associated with Tomocube, Inc., where he continues to develop innovative solutions in the field of mycoplasma detection. His work has been instrumental in advancing the capabilities of imaging technologies in biomedical applications.

Collaborations

Some of his notable coworkers include SuMin Lee and Hye-Jin Kim, who collaborate with him on various projects at Tomocube, Inc. Their combined expertise contributes to the success of their innovative endeavors.

Conclusion

Jaephil Do's contributions to the field of mycoplasma detection through his patented methods highlight his role as a leading inventor in biomedical engineering. His work continues to pave the way for advancements in medical diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…